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A S&year-old Hispanic man, who had been admitted to 
hospital 22 days previously for aseptic meningitis, 
returned to the hospital with fever, photophobia, and 
neck stiffness. His first admission followed 3 days of pro- 
gressive fever and neck stiffness, without headache. An 
oral temperature of 102.4”F was noted; he had a non- 
focal neurologic examination. At that time, computed 
tomographic (CT) scan of the head was unremarkable. 
Table 1 presents lumbar puncture (LP) results on admis- 
sion (LP 1). Ceftriaxone was administered intravenously, 
and the patient’s symptoms resolved after the first hos- 
pital day. He received antibiotics for 4 days. Blood and 
cerebrospinal fluid (CSF) cultures remained negative, and 
the patient was discharged with the diagnosis of aseptic 
meningitis, presumed to be of viral etiology He remained 
well until a few days prior to the second admission when 
his symptoms recurred. 
The patient had a history of heavy alcohol use, 
hepatitis C infection, and liver cirrhosis and had 
undergone portocaval shunt placement 2 years prior to 
the first admission for aseptic meningitis. He was a for- 
mer injection drug user. Enzyme-linked immunosorbent 
assay (ELISA) for human immunodeficiency virus (HIV) 
had been negative 4 months prior to admission. A tuber- 
culin skin test (PPD) had been positive 12 years earlier, 
at which time he received prophylactic therapy. He had 
been born in New York City and had traveled to Puerto 
Rico three times, the last time being several years ear- 
lier. On physical examination at the second admission 
his temperature was 103”F, his neck was supple, and 
there was no indication of adenopathy, papilledema, or 
sinus tenderness. The patient was alert and oriented, 
according to a nonfocal neurologic examination. The 
white blood cell count was 5100/mm3 with a normal dif- 
ferential, the hematocrit was 33%, and the platelet count 
was 123,000/mm3. The serum total protein and albumin 
were 6.5 and 2.5 mg/dL, respectively. Other routine lab- 
oratory values were within normal range, including serum 
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glucose, coagulation studies, and urinalysis. Chest radio- 
graph and repeat CT scan of the head were unremarkable. 
Lumbar puncture revealed an elevated white cell count 
and a low glucose level (see Table 1, LP 2). Serum rapid 
plasma reagin test (RPR) and cryptococcal latex aggluti- 
nation test (CLAT) were negative. The infectious disease 
service was consulted. 
DIFFERENTIAL DIAGNOSIS 
There are numerous possible causes of recurrent lym- 
phocytic meningitis with hypoglycorrhachia in a Wyear- 
old cirrhotic with prior injection drug use and a positive 
PPD. The most likely infectious agents in this case include 
Mycobacterium tuberculosis or fungi (especially C?“yp- 
tococcus; less likely Histoplasma, coccidioidomycosis, 
Blastomyces, Sporotrichum, Candida, and Aspergillus). 
The possibility of partially treated bacterial meningitis or 
parameningeal focus, such as sinusitis, mastoiditis, or 
intracranial abscess, was raised, since the patient’s 
meningeal symptoms improved after a short course of 
ceftriaxone. However, the CSF bacterial culture and assay 
for bacterial antigens were negative from the first admis- 
sion, there was no prior antibiotic use, and both CT scans 
Table 1. Data from Lumbar Punctures Obtained at 
First Hospitalization (LP 1) and 22 days later, 
at Second Admission (LP 2) 
LP 1 LP2 
Appearance 
Cells ioer mm31 
Rei ’ 
White 
Differential (%) 
Neutrophils 
Lymphocytes 
Monocytes 
Glucose (mg/dL)i 
Protein (ma/dL) 
VDRL - 
Ctyptococcal antigen 
Gram stain 
AFB stain 
India ink 
Bacterial antigens* 
Bacterial culture 
Clear Clear 
20 10 
29 244 
4 
94 
2 
51 
32 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
100 
19 
44 
ND 
Negative 
Negative 
Negative 
Negative 
ND 
Negative 
*Opening pressure was not obtained on either occasion. +To converi values for 
glucose to millimoles per liter, multiply by 0.0555. $By latex fixation. ND = Not 
done. 
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of the head were unremarkable. Meningitis due to Liste- 
ria typically causes a neutrophilic pleocytosis, but a lym- 
phocyte predominance can be seen. Although the CSF 
profile in this patient is typical of secondary syphilis or 
neurosyphilis, the CSF Venerial Disease Research Labo- 
ratories test (VDRL) and serum RPR were negative. Many 
viruses can cause the aseptic meningitis syndrome, 
including herpes simplex, enteroviruses, lymphocytic 
choriomeningitis virus, mumps, and HIV Mild hypo- 
glycorrhachia is occasionally seen in meningitis associ- 
ated with most viral agents, but a CSF glucose of 19 mg/dL 
(as seen in LP 2) is unlikely to be seen in such cases. Non- 
Infectious causes of meningitis to consider in this case 
include carcinomatous meningitis and sarcoidosis. 
WORKING DIAGNOSIS 
The patient was presumed to have tuberculous menin- 
gitis, and treatment was started with isoniazid, rifampin, 
pyrazinamide, and ethambutol. 
CLINICAL COURSE 
Four days into the second hospitalization, the CSF fungal 
culture from LP 2 grew many colonies of Cryptococcus 
neoformans. Two days later, CSF culture from the first 
admission grew a single colony of the same organism. 
Anti-tuberculous medications were stopped; the patient 
was treated with intravenous amphotericin B and all 
symptoms resolved rapidly A repeat HIV ELISA was neg- 
ative (for both HIV-l and HIV-a), but T-cell subset analy- 
sis showed a CD4 count of 105/mm3 and a CD4:CDS ratio 
of 1.3. Lumbar puncture 12 days after initiating antiftm- 
gal therapy revealed normalization of CSF parameters. 
After 14 days of amphotericin B (total dose 660 mg), 
therapy was switched to oral fluconazole, 400 mg/day. 
Two months later, still on fluconazole, the patient was 
asymptomatic, and his CD4 count was 380/mm3 .with a 
CD4:CDS ratio of 1.9. 
DISCUSSION 
Cryptococcus neoformans is now the most common CSF 
isolate at many New York City hospitals.’ Most cases 
occur in HIV-infected patients with CD4 counts less than 
100/mm3. Prior to 1980, most cases of cryptococcal 
meningitis occurred in patients with altered cellular 
immunity from other causes, including organ transplan- 
tation, chronic corticosteroid use, lymphoreticular neo- 
plasms (especially Hodgkin’s disease), and sarcoidosis.2-5 
In the case described here, the patient had a history of 
heavy alcohol use and hepatic cirrhosis, which, along 
with diabetes and pregnancy, have been associated with 
cryptococcal meningitis.6 Before the AIDS epidemic, 
almost half of the patients with cryptococcal meningitis 
lacked clinically apparent immunologic defects. 
Smith et al and others have recently described sev- 
eral patients with opportunistic infections and depressed 
CD4 counts without evidence of HIV infection, so-called 
idiopathic CD4 lymphocytopenia.7~8 Cryptococcal menin- 
gitis was seen in several of these patients, raising the pos- 
sibility that many patients with cryptococcal meningitis 
previously thought to lack immunologic defects may have 
also had decreased CD4 levels. Few data have been pub- 
lished on patients with idiopathic CD4 lymphocytope- 
nia; this syndrome may result from a variety of rare 
defects in CD4 cell regulation, production, or destruc- 
tion. The patient described in this report had a depressed 
CD4 count and a negative ELISA for HIV-l and HIV-2, 
consistent with idiopathic CD4 lymphocytopenia. How- 
ever, he did not meet established criteria for this syn- 
drome because other tests to rule out HIV infection, such 
as p24 antigen or polymerase chain reaction (PCR) were 
not performed, and T-cell subsets were not rechecked 
until 2 months into recovery, at which time the CD4 
count had risen (albeit not into the normal range). 
Cryptococcal meningitis has been reported in 
patients infected with human T-cell lymphotropic virus 
type 1 (HTLV-1).9a10 In many of these patients, the devel- 
opment of opportunistic infections such as cryptococ- 
cal meningitis can be a harbinger for the onset of T-cell 
leukemia.9 Analysis for HTLV-1 infection was not done in 
this case. 
Diagnosing cryptococcal meningitis in patients with- 
out underlying immunodeficiency can be challeng- 
ing.2-4J1-13 History of exposure to Cryptococcus neofor- 
mans is rarely helpful because the organism is ubiqui- 
tous. Symptoms may be chronic, subacute, or acute in 
onset, and can range from headache, fever, meningismus, 
nausea, and vomiting to confusion, dementia, cranial 
nerve palsies, and coma. Lumbar puncture is essential 
for diagnosis, and typically shows elevated opening pres- 
sure, lymphocytic pleocytosis, elevated protein, and 
hypoglycorrhachia. Cerebrospinal fluid India ink stain is 
a rapid test, but is inoculum-dependent and therefore 
often negative in low grade infections. False positive India 
ink stains are common; red cells, lymphocytes, and talc 
powder may be confused for Cryptococcus neoformans 
(which is 2-12 pm in diameter). The CSF CLAT can be 
performed rapidly and is highly specific (97-100%) and 
sensitive (98-100%);14 therefore, it is the single best test 
for diagnosing crytococcal meningitis. Cerebrospinal fluid 
fungal culture is positive in most cases but may take sev- 
eral weeks to grow. Blood cultures and the serum CLAT 
also can be helpful in establishing the diagnosis; how- 
ever, these indicate active extrameningeal disease, which 
is unusual in the non-AIDS patient. 
Amphotericin B, with or without flucytosine, is the 
mainstay of therapy for cryptococcal meningitis. Flu- 
conazole is an effective alternative although it has not 
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been studied in patients without AIDS.lj To prevent 
relapse following treatment, suppressive therapy with 
oral fluconazole is indicated in patients with chronic 
severe immunosuppression (secondary to AlDS, organ 
transplantation, or immunosuppressive drugs) where the 
relapse rate can be 40 to 60%.16-19 Traditionally, no sup- 
pressive therapy is given to patients without severe 
immunosuppression, in whom the relapse rate is approx- 
imately 10%. Factors associated with poor outcome 
include mental deterioration, elevated CSF pressure, lack 
of inflammatory cells in the CSF, positive India ink stain, 
and hypoglycorrhachia.’ Procedures that will reduce high 
CSF pressures may also be required, such as therapeutic 
LPs or shunt placement.20 
This case illuminates the difficulties in establishing 
the diagnosis of cryptococcal meningitis in the non-AIDS 
patient. The initial LP was nonspecific, and although the 
second LP was more helpful, both of the rapid tests (India 
ink and CLAT) were negative. The pathology of crypto- 
coccal meningitis has many similarities to tuberculous 
meningitis.21 Recurrence of symptoms after several weeks 
with a high colony count in CSF culture could represent 
rupture of a cryptococcal granuloma into the subarach- 
noid space. This patient’s first episode may be more 
analogous to the “serous tuberculous meningitis” first 
described by Edith Lincoln, presumably attributable to 
abortive rupture of a cryptococcal granuloma into the 
subarachnoid space.22 
In patients with moderately intact cellular immunity 
the burden of organisms is often low, and in this situa- 
tion the India ink is usually negative; the culture, if pos- 
itive, may take several weeks to grow, and the CLAT may 
be negative.14zz3 The CIAT also may be negative due to 
the lower sensitivity of some commercially available cryp- 
tococcal antigen kits.‘* In these kits, false negative CLATs 
may be related to a higher negative cutoff chosen to min- 
imize false positive results. 
Cryptococci with relatively small capsules are some- 
times seen in tissue specimens and in India ink stain of 
fresh CSF and primary cultures.z4-26 Because culture con- 
ditions can greatly influence capsular elaboration, the 
significance of this finding is unclear.27~28 Some reports 
have correlated infection with poorly or nonencapsu- 
lated Cryptococcus neoformans and low or undetectable 
antigen titers.29,30 In the patient presented here, CSF India 
ink was negative and India ink stain of the primary cul- 
ture revealed normal capsule size. 
In summary, cryptococcal meningitis should be sus- 
pected in any patient with altered cellular immunity, and 
appropriate diagnostic tests of the CSF should be per- 
formed, including India ink, CLAT, and fungal culture. In 
patients without AIDS or other severe immunosuppres- 
sion, the diagnosis may be more difficult to make, 
because both the India ink stain and the CLAT, which 
are dependent on the number of organisms, are likely to 
be negative, and the culture may take longer to grow. 
Therapy consists of amphotericin B with or without 
flucytosine; fluconazole is a frequently used alternative 
especially after initial control of symptoms and signs. 
Chronic suppression with oral fluconazole is required in 
the setting of severe immunodeficiency to prevent 
relapse. 
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